The AI trade came roaring back. Meta rose 12.9% over the week to 25 September, including 11.34% on Monday after its Muse AI assistant reached the top of Apple's free app chart, and its chip supplier AMD gained 12.65% and passed a $1 trillion market value. The Nasdaq 100 climbed 3.25%. Europe lagged: the STOXX 600 rose only 0.5% as Novo Nordisk fell 10.14% and carmakers slid again.
The week at a glance
- Meta jumped 11.34% on Monday as its Muse assistant became the most downloaded free app on Apple's App Store.
- AMD rose 9.95% the same day and became the fourth US chipmaker worth more than $1 trillion.
- The Nasdaq set its first record close since June, and the Nasdaq 100 ended the week up 3.25%.
- Novo Nordisk lost 10.14% after its capital markets day; BMW fell 7.75% to near a six-year low.
Meta's Muse Assistant Restarts the AI Trade
A week earlier, calls from AI bosses for a slower pace of development had knocked chip stocks. This week investors bought them back. On Monday Meta's new Muse AI assistant reached the top spot among free downloads on Apple's App Store, and the shares rose 11.34%, the biggest one-day move of any tracked stock that week. Meta added another 4.5% on Thursday and ended the week at $751.66.
AMD, a key Meta supplier, rose 9.95% on Monday and became the fourth US chipmaker valued at more than $1 trillion. It finished the week up 12.65% at $630.63. The Nasdaq posted its first record close since June that day.
Europe's chip names followed for a while. ASML rose 5.3% on the week and Infineon gained 4.35% on Monday. But Infineon fell 3.94% on Thursday as the US AI trade wobbled, and ended up just 1.52%. Siemens rose 5.42%, the best European performer among tracked stocks.
Novo Nordisk Fails to Win Over Investors
Novo Nordisk used its capital markets day on Monday to show new data for CagriSema, its next obesity injection. In a late-stage trial in people with diabetes, the drug's 1 mg dose produced average weight loss of 12.4%, against 9.1% for Eli Lilly's tirzepatide at a 5 mg dose. Novo aims to launch CagriSema in early 2027, with a US decision on its use for weight management expected in the fourth quarter.
Analysts were not convinced. They questioned Novo's pricing power and its dealmaking strategy, with Wegovy facing patent expiries after 2030. BMO's Evan Seigerman said the low-dose data was encouraging but less impactful, because tirzepatide has already beaten higher CagriSema doses in obesity. Novo shares fell 7.65% on Monday and 10.14% over the week, the worst move among tracked stocks.
Carmakers Slide as Energy and Capital Worries Return
The car sector's slide continued after the previous week's Volkswagen profit warning. Volkswagen was removed from the Euro Stoxx 50 on Monday, its first removal in 15 years, with its shares more than 75% below their 2021 highs. Porsche SE, which owns 53.3% of Volkswagen's ordinary shares, fell 2.6% that day.
BMW fell 2.7% to €56.30 on Thursday, near a six-year low, ahead of its capital markets day on 29 and 30 September. UBS expects BMW to set a 2028 car margin target of 3% to 5%, below the 5.1% consensus, and sees a capital return to shareholders as unlikely. BMW ended the week down 7.75%, Volkswagen 6.27% and Mercedes-Benz 6.16%. Stellantis lost 4.07%.
Oil and gas costs came back into focus on Thursday. European shares fell as fuel and gas prices rose on concern that the naval blockade in the Persian Gulf could last longer, and on signals that Washington might ban diesel exports. Norges Bank raised its policy rate the same day.
UBS shares fell 1.7% on Thursday after the Swiss upper house ruled that the bank must hold 90% CET1 capital against its foreign subsidiaries. UBS called it "excessive tightening". Dior jumped 16% after the Arnault family group set out a cash offer for the shares it does not own, at an indicative €469 a share. Kering fell 2.8% on Monday on worries about weak Chinese demand. Gold lost 2.34%.
Scorecard: Indices, Winners and Losers
| Index | Close | Week |
|---|---|---|
| Euro Stoxx 50 | 6,302.82 | +1.07% |
| STOXX 600 | 638.65 | +0.50% |
| DAX | 25,408.64 | +0.41% |
| CAC 40 | 8,077.80 | +0.16% |
| FTSE 100 | 10,695.30 | +0.34% |
| FTSE MIB | 51,867.00 | +0.62% |
| IBEX 35 | 19,700.10 | +0.95% |
| S&P 500 | 7,743.41 | +1.21% |
| Nasdaq 100 | 30,608.13 | +3.25% |
Winners and losers
| Stock | Week |
|---|---|
| Meta | +12.90% |
| AMD | +12.65% |
| Siemens | +5.42% |
| Novo Nordisk | -10.14% |
| BMW | -7.75% |
| Volkswagen | -6.27% |
Allianz also had a weak week, down 4.47%, including a 3.97% drop on Wednesday, and Ericsson lost 5.02%.
What Investors Watch Next
BMW's capital markets day next week will show whether UBS's cautious margin call is right. For Novo, the next test is the US decision on CagriSema, due in the fourth quarter. And the AI rally now has to hold up with US 10-year yields above 5%: Europe's tech names showed on Thursday how quickly they still react when the US AI trade turns.
Sources
- Semafor: AMD reaches a $1 trillion market cap as chip stocks drive rally
- Reuters via Euronext: Novo says CagriSema shows greater weight loss than Lilly rival in diabetes patients
- Alliance News via VZ VermögensZentrum: Financials and miners rise, luxury stocks fall
- Alliance News via VZ VermögensZentrum: BMW down before investor day, Henkel gets peer boost
- Trading Economics: Euro area stock market update, 24 September
- BMK News market data (delayed exchange data)








